October 8, 2025Deleted JournalOpen Access

Safety and efficacy of liraglutide in patients with obesity

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Prospective study reveals significant weight loss with liraglutide in obese patients, suggesting benefits across ND, pre-DM, and T2DM populations.

Liraglutide resulted in significant reductions in body weight and BMI across all metabolic states.
The greatest weight loss occurred in T2DM patients, averaging 13.28 kg over six months.
Improvements in liver enzymes and lipid profiles, particularly LDL and triglycerides, were noted in T2DM patients.
Higher baseline HbA1c levels correlated with greater weight loss in pre-DM and T2DM groups.

Durrani et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Prospective study reveals significant weight loss with liraglutide in obese patients, suggesting benefits across ND, pre-DM, and T2DM populations.